Treatment patterns and metastasectomy among mCRC patients receiving chemotherapy and biologics

References

• O'Neil BH, Goldberg RM. Innovations in chemotherapy for metastatic colorectal cancer: an update of recent clinical trials. Oncologist 2008;13:1074-83
   PubMed Web of Science ®Google Scholar
• Ardavanis A, Kountourakis P, Mantzaris I, et al. Bevacizumab added to the irinotecan and capecitabine combination for advanced colorectal cancer: a well-tolerated, active and convenient regimen. Anticancer Res 2008;28:3087-92
   PubMed Web of Science ®Google Scholar
• Jonker DJ, O'Callaghan CJ, Karapetis CS, et al. Cetuximab for the treatment of colorectal cancer. N Engl J Med 2007;357:2040-8
   PubMed Web of Science ®Google Scholar
• Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335-42
   PubMed Web of Science ®Google Scholar
• Tyagi P. Vatalanib (PTK787/ZK 222584) in combination with FOLFOX4 versus FOLFOX4 alone as first-line treatment for colorectal cancer: preliminary results from the CONFIRM-1 trial. Clin Colorectal Cancer 2005;5:24-6
   PubMedGoogle Scholar
• Bir A, Tan W, Wilding GE, et al. 5-Fluorouracil, leucovorin and oxaliplatin plus bevacizumab in the first-line treatment of metastatic colorectal cancer: a single-institute study. Oncology 2007;72:4-9
   PubMed Web of Science ®Google Scholar
• Grothey A, Surgue MM, Purdie DM, et al. Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE). J Clin Oncol 2008;26:5326-34
   PubMed Web of Science ®Google Scholar
• Reddy GK. The addition of bevacizumab to FOLFOX4 prolongs survival in relapsed colorectal cancer: interim data from the ECOG 3200 trial. Clin Colorectal Cancer 2005;4:300-1
   PubMedGoogle Scholar
• Giantonio BJ, Catalano PJ, Meropol NJ, et al. Bevacizumab in combination with oxaliplatin, fluoroucil, and leukovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol 2007;25:1539-44
   PubMed Web of Science ®Google Scholar
• Goldberg RM. Therapy for metastatic colorectal cancer. Oncologist 2006;11:981-7
   PubMed Web of Science ®Google Scholar
• Alberts SR. Use of neoadjuvant and postoperative chemotherapy with surgical resection of colorectal cancer hepatic metastases. Curr Colorectal Cancer Rep 2008;4:100-5
   Google Scholar
• Folprecht G, Grothey A, Alberts S, et al. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol 2005;16:1311-19
   PubMed Web of Science ®Google Scholar
• Bismuch H, Adam R, Levi F, et al. Resection of nonresectable liver metastases from colorectal cancer after neojaduvant chemotherapy. Ann Surg 1996;224:509-20
   PubMed Web of Science ®Google Scholar
• Pozzo C, Basso M, Cassano A, et al. Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. Ann Oncol 2004;15:933-9
   PubMed Web of Science ®Google Scholar
• Leonard GD, Brenner B, Kemeny NE. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol 2005;23:2038-48
   PubMed Web of Science ®Google Scholar
• Cunningham D, Humblet Y, Siena S, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 2004;351:337-45
   PubMed Web of Science ®Google Scholar
• Kabbinavar FF, Hambleton J, Mass RD, et al. Combined analysis of efficacy: The addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer. J Clin Oncol 2005;23:3706-12
   PubMed Web of Science ®Google Scholar
• Venook A. Critical evaluation of current treatments in metastatic colorectal cancer. Oncologist 2005;10:250-61
   PubMed Web of Science ®Google Scholar
• Delaunoit T, Alberts SR, Sargent DJ, et al. Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741. Ann Oncol 2005;16:425-9
   PubMed Web of Science ®Google Scholar
• Min BS, Kim NK, Ahn JB, et al. Cetuximab in combination with 5-fluorouracil, leucovorin and irinotecan as a neoadjuvant chemotherapy in patients with initially unresectable colorectal liver metastases. Onkologie 2007;30:637-43
   PubMed Web of Science ®Google Scholar
• Paramore C, Thomas S, Knopf K, et al. Estimating costs of care for patients with newly diagnosed metastatic colorectal cancer. Clin Colorectal Cancer 2006;6:52-8
   PubMed Web of Science ®Google Scholar
• SEER Stat Fact Sheets. (2009) http://seer.cancer.gov/statfacts/html/colorect.html [Last accessed 19 June, 2009]
   Google Scholar